Mastocytosis: An unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells

American Journal of Clinical Pathology

Volumn 132, Issue 3, 2009, Pages 438-447

  Horny, Hans Peter ^a  

^a Institut für Pathologie   (Germany)

Author keywords

Bone marrow; KITD816V; Mast cell; Mast cell leukemia; Mastocytosis; Systemic mastocytosis; Systemic mastocytosis with associated hematologic non mast cell clonal disease

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; STEM CELL FACTOR RECEPTOR; TRYPTASE;

ANTIGEN EXPRESSION; BONE MARROW; BONE MARROW BIOPSY; CELL INFILTRATION; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOCYTIC INFILTRATION; MAST CELL; MAST CELL LEUKEMIA; MORBIDITY; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; URTICARIA PIGMENTOSA; ADULT; AGED; BONE MARROW CELL; CASE REPORT; FEMALE; MALE; MASTOCYTOSIS; MIDDLE AGED; ORGANIZATION; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

ADULT; AGED; BONE MARROW CELLS; CONGRESSES AS TOPIC; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MASTOCYTOSIS; MIDDLE AGED;

EID: 69849098126     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPPXHMN5CJOXHZ     Document Type: Conference Paper

References (38)

1. Valent P, Horny H-P, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal: conference report of "Year 2000 Working Conference on Mastocytosis." Leuk Res. 2001;25:603-625.
2. Horny H-P, Metcalfe DD, Bennett J, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:54-63.
3. Sotlar K, Horny H-P, Simonitsch I, et al. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol. 2004;28:1319-1325. (Pubitemid 39336370)
4. Sotlar K, Marafioti T, Griesser H, et al. Detection of c-kit mutation Asp-816-Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukemia. Mol Pathol. 2000;53:188-193. (Pubitemid 30603073)
5. Feger F, Ribadeau Dumas A, Leriche L, et al. Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts. Int Arch Allergy Immunol. 2002;127:110-114. (Pubitemid 34264196)
6. Sperr WR, Jordan JH, Fiegl M, et al. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol. 2002;128:136-141. (Pubitemid 34639022)
7. Horny H-P, Valent P. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res. 2001;25:543-551. (Pubitemid 32506761)
8. Horny HP, Valent P. Histopathological and immunophenotypical aspects of mastocytosis. Int Arch Allergy Immunol. 2002;127:115-117.
9. Escribano L, Orfao A, Diaz-Agustin B, et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implication. Blood. 1998;91:2731-2736. (Pubitemid 28227522)
10. Horny H-P, Ruck M, Wehrmann M, et al. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. Br J Haematol. 1990;76:186-193. (Pubitemid 20342673)
11. Sperr WR, Horny H-P, Lechner K, et al. Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. Leuk Lymphoma. 2000;37:473-486. (Pubitemid 30219056)
12. Horny H-P, Sotlar K, Sperr WR, et al. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol. 2004;57:604-608. (Pubitemid 38725760)
13. Sotlar K, Bache A, Stellmacher F, et al. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a clonal hematological non-mast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn. 2008;10:58-66. (Pubitemid 351184836)
14. Bernd HW, Sotlar K, Lorenzen J, et al. Acute myeloid leukemia with t(8;21) associated with "occult" mastocytosis: report of an unusual case and review of the literature. J Clin Pathol. 2004;57:324-328. (Pubitemid 39005216)
15. Caplan RM. The natural course of urticaria pigmentosa. Arch Dermatol. 1963;87:146-157.
16. Valent P, Akin C, Sperr WR, et al. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res. 2003;27:635-641. (Pubitemid 36398099)
17. Travis WD, Li CY, Hogaland HC, et al. Mast cell leukemia: report of a case and review of the literature. Mayo Clin Proc. 1986;61:957-966. (Pubitemid 17205206)
18. Horny H-P, Parwaresch MR, Kaiserling E, et al. Mast cell sarcoma of the larynx. J Clin Pathol. 1986;39:596-602.
19. Kojima M, Nakamura S, Itoh H, et al. Mast cell sarcoma with tissue eosinophilia arising in the ascending colon. Mod Pathol. 1999;12:739-743. (Pubitemid 29354889)
20. Guenther PP, Huebner A, Sobottka SB, et al. Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. J Pediatr Hematol Oncol. 2001;23:134-138. (Pubitemid 32162678)
21. Jordan JH, Fritsche-Polanz R, Sperr WR, et al. A case of smouldering mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val. Leuk Res. 2001;25:627-634. (Pubitemid 32506769)
22. Hauswirth A, Sperr WR, Ghannadan M, et al. A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy. Leuk Res. 2002;26:601-606. (Pubitemid 34462175)
23. Akin C, Fumo G, Yavuz AS, et al. A novel form of mastocytosis with a transmembrane c-kit mutation and response to imatinib. Blood. 2004;103:3222-3225. (Pubitemid 38451702)
24. Sotlar K, Saeger W, Stellmacher F, et al. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis. J Clin Pathol. 2006;59:875-878. (Pubitemid 44211753)
25. Valent P, Sperr WR, Samorapoompichit P, et al. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis. Leuk Res. 2001;25:595-602. (Pubitemid 32506767)
26. Valent P, Samorapoompichit P, Sperr WR, et al. Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells. Hematol J. 2002;3:90-94. (Pubitemid 34555535)
27. Sperr WR, Jordan JH, Baghestanian M, et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood. 2001;98:2200-2209.
28. Pardanani A, Ketterling RP, Brockman SR, et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood. 2003;102:3093-3096. (Pubitemid 37314742)
29. Horny H-P, Sotlar K, Stellmacher F, et al. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-bm): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol. 2006;59:298-302. (Pubitemid 43344893)
30. Li WV, Kapadia SB, Sonmez-Alpan E, et al. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies. Mod Pathol. 1996;9:982-988. (Pubitemid 26356740)
31. Horny H-P, Sillaber C, Menke D, et al. Diagnostic utility of staining for tryptase in patients with mastocytosis. Am J Surg Pathol. 1998;22:1132-1140. (Pubitemid 28411072)
32. Li C-Y. Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry. Leuk Res. 2001;25:537-541.
33. Jordan H, Walchshofer S, Jurecka W, et al. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-xL. Hum Pathol. 2001;32:545-552. (Pubitemid 32506526)
34. Horny H-P, Sotlar K, Stellmacher F, et al. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). J Clin Pathol. 2006;59:264-268. (Pubitemid 43344887)
35. Horny H-P, Ruck M, Kaiserling E. Spleen findings in generalized mastocytosis: a clinicopathologic study. Cancer. 1992;70:459-468.
36. Wimazal F, Schwarzmeier J, Sotlar K, et al. Splenic mastocytosis: report of two cases and detection of the transforming somatic c-kit mutation D816V. Leuk Lymphoma. 2004;45:723-729. (Pubitemid 38256032)
37. Sperr WR, Escribano L, Jordan JH, et al. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res. 2001;25:529-536. (Pubitemid 32506759)
38. Maric I, Robyn J, Metcalfe DD, et al. KITD816V-associated systemic mastocytosis with eosinophilia and FIP1L1/ PDGFRA-associated chronic eosinophilic leukemia are distinct entities. J Allergy Clin Immunol. 2007;120:680-687. (Pubitemid 47320757)